Khona began with rare cannabinoids and a stubborn biological problem: long pathways leak value at every step. Now the four-person Colorado biotech is aiming its microbial assembly line at a larger prize - domestic supplies of pharmaceutical starting materials and APIs.
Allonnia is a Boston-based environmental biotechnology company that uses biology and engineered systems to solve stubborn contamination and resource-recovery problems. Spun out of Ginkgo Bioworks' Ferment Consortium in 2020, it removes PFAS from water at scale using SAFF foam-fractionation technology and is commercializing biological methods to recover critical minerals and rare earth elements from ore. The company has raised more than $100 million to bring 'bio-ingenuity' to water treatment and mining.